Chester Chae

Chester Chae is an accomplished professional with a strong background in regulatory affairs and biotechnology. Currently serving as the Manager of Regulatory Affairs at ORIC Pharmaceuticals Inc. since March 2022, Chester also contributes to the SoCal PDA Young Professional Committee with the Parenteral Drug Association since July 2020. Previous roles include Manager of Regulatory Affairs at Sorrento Therapeutics, Inc., and Senior Associate in CMC Regulatory Affairs at Amgen. Chester's experience in consulting for injector devices technical due diligence at BioMarin Pharmaceutical Inc. and project management for a diabetes program at Pomona Valley Hospital Medical Center underscores expertise in both regulatory and project management domains. Academic qualifications include a Bachelor's Degree in Chemistry from Hanover College and a Master's degree in Biotechnology from Keck Graduate Institute, complemented by a study abroad program at the University of Wollongong.